HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

viscum album peptide (Iscador)

tumor reducing peptide isolated from Viscum album extract (Iscador); NSC 635089 is a peptide from the extract
Also Known As:
Iscador; Iscador-Qu; NSC 635089; VA QuFrF; Viscum album QuFrF
Networked: 84 relevant articles (8 outcomes, 26 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ziegler, Renatus: 6 articles (03/2009 - 10/2006)
2. Büssing, Arndt: 5 articles (01/2012 - 11/2005)
3. Grossarth-Maticek, Ronald: 4 articles (06/2010 - 10/2006)
4. Grossarth-Maticek, R: 3 articles (03/2008 - 05/2001)
5. Zänker, Kurt S: 2 articles (01/2014 - 08/2005)
6. Hanisch, Jürgen: 2 articles (01/2014 - 01/2004)
7. Matthes, Harald: 2 articles (01/2014 - 01/2014)
8. Bock, Paul R: 2 articles (01/2014 - 01/2004)
9. Bar-Sela, Gil: 2 articles (03/2013 - 01/2006)
10. Raak, Christa: 2 articles (01/2012 - 01/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
08/01/2004 - "Complementary therapy of patients with primary, non-metastatic breast carcinoma with the mistletoe extract Iscador was safe and in comparison to the control group within the same study cohort showed considerably fewer ADRs attributed to concurrent conventional therapy, reduced disease symptoms, and suggested a significant improvement of survival. "
08/01/2004 - "The purpose of the study was to evaluate the therapeutic efficacy and safety of a long-term complementary therapy of primary, non-metastatic breast carcinoma patients treated with standardized European mistletoe extract Iscador("mistletoe") in addition to the conventional adjuvant oncologic therapy, and compared to the control group treated with the conventional therapy alone. "
01/01/2004 - "The purpose of the study was to evaluate the therapeutic efficacy and safety of long-term complementary therapy in primary, non-metastatic mammary carcinoma patients in UICC stage I-III with a standardized European mistletoe extract (Viscum album L., Iscador, "mistletoe extract") given in addition to conventional adjuvant oncologic therapy (i.e. "
02/01/1979 - "A comparison of the results of the two collectives shows that Iscador a special preparation of viscum album, is a useful and effective treatment of carcinoma of the ovary, particularly since it usually does not cause serious and undesired side effects. "
01/01/1969 - "[Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma]."
3. Neoplasm Metastasis (Metastasis)
4. Lymphoma (Lymphomas)
5. Non-Hodgkin Lymphoma (Lymphosarcoma)

Related Drugs and Biologics

1. viscum album peptide (Iscador)
2. Carboplatin (JM8)
3. Vincristine (Oncovin)
4. abnoba viscum
5. Matrix Metalloproteinases
6. P-Glycoprotein
7. Cytokines
8. Interleukin-6 (Interleukin 6)
9. Recombinant Interferon Type I
10. Radioactive Fallout (Fallout, Radioactive)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Adjuvant Chemotherapy
3. Intravenous Infusions
4. Intraperitoneal Injections
5. Heterologous Transplantation (Xenotransplantation)